Damora Therapeutics, Inc. (DMRA)
30.74
+0.43
(+1.42%)
USD |
NASDAQ |
Aug 25, 16:00
30.74
0.00 (0.00%)
After-Hours: 18:41
Damora Therapeutics 1 Year Total Returns (Daily) : 807.5% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 807.5% |
| August 21, 2026 | 811.8% |
| August 20, 2026 | 796.8% |
| August 19, 2026 | 862.6% |
| August 18, 2026 | 843.6% |
| August 17, 2026 | 819.8% |
| August 14, 2026 | 804.1% |
| August 13, 2026 | 814.6% |
| August 12, 2026 | 844.6% |
| August 11, 2026 | 798.2% |
| August 10, 2026 | 774.0% |
| August 07, 2026 | 817.8% |
| August 06, 2026 | 778.8% |
| August 05, 2026 | 806.8% |
| August 04, 2026 | 786.9% |
| August 03, 2026 | 791.1% |
| July 31, 2026 | 781.2% |
| July 30, 2026 | 779.8% |
| July 29, 2026 | 689.1% |
| July 28, 2026 | 680.4% |
| July 27, 2026 | 685.1% |
| July 24, 2026 | 658.0% |
| July 23, 2026 | 668.6% |
| July 22, 2026 | 723.9% |
| July 21, 2026 | 817.7% |
| Date | Value |
|---|---|
| July 20, 2026 | 819.8% |
| July 17, 2026 | 762.5% |
| July 16, 2026 | 764.0% |
| July 15, 2026 | 771.0% |
| July 14, 2026 | 694.6% |
| July 13, 2026 | 692.1% |
| July 10, 2026 | 722.2% |
| July 09, 2026 | 805.3% |
| July 08, 2026 | 729.2% |
| July 07, 2026 | 823.1% |
| July 06, 2026 | 741.8% |
| July 02, 2026 | 746.9% |
| July 01, 2026 | 694.4% |
| June 30, 2026 | 662.8% |
| June 29, 2026 | 607.9% |
| June 26, 2026 | 624.6% |
| June 25, 2026 | 558.0% |
| June 24, 2026 | 546.7% |
| June 23, 2026 | 580.7% |
| June 22, 2026 | 608.8% |
| June 18, 2026 | 537.5% |
| June 17, 2026 | 565.2% |
| June 16, 2026 | 521.1% |
| June 15, 2026 | 499.1% |
| June 12, 2026 | 520.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 15.19% |
| Alnylam Pharmaceuticals, Inc. | -48.06% |
| Anika Therapeutics, Inc. | 121.1% |
| Savara, Inc. | 75.95% |
| Vericel Corp. | 14.23% |